The Lawyer Africa Elite 2014 features an in-depth look at 46 leading independent firms’ strategies in 15 key sub-Saharan jurisdictions, as well as the views of in-house counsel from some of Africa’s largest companies... Read more
This year, The Lawyer’s annual ranking of the largest UK law firms by turnover is available as an interactive, digital benchmarking tool. For the first time this will allow you to manipulate each data set against the metrics of your choice.
British pharmaceutical giant GlaxoSmithKline (GSK) has been embroiled in bribery probes in China. In the last few days the Chinese authorities have revealed details of the alleged fraudulent practices at the pharma giant, even before a criminal investigation is concluded.
Yesterday (15 July), lead investigator, Gao Feng, alleged that GSK had funnelled more than RMB3bn (£323m) to doctors and government officials to persuade them to prescribe GSK drugs.
Gao claimed that, among other things, travel agencies had acted as conduits to pass bribes to government officials, doctors, hospitals and industry associations. GSK had used more than 700 travel agencies and consultancies in which to transfer hundreds of millions in bribes in the last six years, it was alleged.
The authorities have so far named the four Chinese executives arrested in connection to the bribery allegations. GSK’s China head of legal April Zhaom is believed to be among the detained executives.